Lv6
1790 积分 2021-08-17 加入
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity
1个月前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
1个月前
已完结
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trials
1个月前
已完结
Targeting thymine DNA glycosylase induces synthetic lethality in p53-deficient cancers
1个月前
已完结
Cell cycle control in cancer
4个月前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
4个月前
已完结
Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies
4个月前
已完结
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1–DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
5个月前
已完结
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
5个月前
已完结
Cyclin E, a Potential Prognostic Marker in Breast Cancer
6个月前
已关闭
皖公网安备34019202002308
